Inhibition of cell-cycle progression in HeLa cells by HY52, a novel cyclin-dependent kinase inhibitor isolated from Bauhinia forficata

Cancer Letters

Volumn 233, Issue 1, 2006, Pages 89-97

  Lim, Haeyoung ^a   Kim, Min Kyoung ^a   Lim, Yoongho ^b   Cho, Youl Hee ^a   Lee, Chul Hoon ^a  

^a Hanyang University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Bauhinia forficata; Cell cycle arrest; HY52; Pata de Vaca

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HY 52; PROTEIN; PROTEIN P21 KIP1; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BAUHINIA FORTICATA; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PURIFICATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IMMUNOPRECIPITATION; IN VITRO STUDY; MEDICINAL PLANT; METAPHASE; NICK END LABELING; PHARMACODYNAMICS; PLANT LEAF; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STRUCTURE ACTIVITY RELATION; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BAUHINIA; CDC2 PROTEIN KINASE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; CYCLOHEXANES; HELA CELLS; HUMANS; HYDRAZINES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RETINOBLASTOMA PROTEIN;

BAUHINIA; BAUHINIA FORFICATA;

EID: 32344442288     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.03.002     Document Type: Article

References (31)

1. J. Pines Cyclins and cyclin-dependent kinases: a biochemical view Biochem. J. 308 1995 697 711
2. X. Grana, and E.P. Reddy Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CDIs) Oncogene 11 1995 211 219
3. C.J. Sherr Cancer cell cycles Science 274 1996 1672 1677
4. C.J. Sherr, J.M. Roberts, and CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev. 13 1999 1501 1512
5. H. Lim, M. Kim, Y. Cho, J. Kim, Y. Lim, and C.-H. Lee Inhibition of cell cycle progression and induction of apoptosis in HeLa cells by HY558-1, a novel CDK inhibitor isolated from Penicillium minioluteum F558 J. Microbiol. Biotechnol. 14 2004 978 984
6. M. Kim, Y. Cho, J. Kim, M. Chun, S. Lee, and Y. Lim Inhibition of cell-cycle progression in human promyelocytic leukemia HL-60 cells by MCS-C2, novel cyclin-dependent kinase inhibitor J. Microbiol. Biotechnol. 13 2003 607 612
7. C.-H. Lee, H. Lim, M. Kim, Y. Cho, D. Oh, and C. Kim Isolation and biological properties of novel cell cycle inhibitor, HY558, isolated from Penicillium minioluteum F558 J. Microbiol. Biotechnol. 12 2002 470 475
8. N.P. Pavletich Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and CIP and INK4 inhibitors J. Mol. Biol. 287 1999 821 828
9. D. Morgan Cyclin dependent kinases: engines, clocks and microprocessors Annu. Rev. Cell Dev. Biol. 13 1997 261 291
10. C.J. Sherr, and J.M. Roberts Inhibitors of mammalian G1 cyclin-dependent kinases Genes Dev. 9 1995 1149 1163
11. J. Bartek, J. Bartkova, and J. Lukas The retinoblastoma protein pathway and the restriction point Curr. Opin. Cell Biol. 8 1996 805 814
12. A.S. Lundberg, and R.A. Weinberg Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes Mol. Cell Biol. 18 1998 753 761
13. R.A. Weinberg The retinoblastoma protein and cell cycle control Cell 81 1995 323 330
14. N. Dyson The regulation of E2F by pRb-family proteins Genes Dev. 12 1998 2245 2262
15. T.M. Guadagno, and J.W. Newport Cdk2 kinase is required for entry into mitosis as a positive regulator of cdc2-cyclin B kinase activity Cell 84 1996 73 82
16. D. Morgan Principles of CDK regulation Nature 374 1995 131 134
17. H.L. Bondt, J. Rosenblatt, J. Jancarik, H.D. Jones, D. Morgan, and S.H. Kim Crystal structure of cyclin-dependent kinase 2 Nature 363 1993 595 602
18. G.L. Cruz Dicionario Das Plantas Uteis Do Brasil fifth ed. 1995 Rio de Janeiro, Brazil Bertrand
19. E.R. de Almeida, Plantas Medicinais Brasileiras, Conhecimentos Populares e Cientificos. Hemus Editora Ltda. Sau Paulo, Brazil, (1993).
20. S.A. Herboper, Package inserts and instructions for use for packaged medicinal plants sold by Herboper, SA., Lima, Peru, (1997).
21. A. Bernardes A. Pocketbook of Brazilian Herbs 1984 A Shogun Editora e Arta Ltda Rio de Janeiro, Brazil
22. R. Almeida, M.F. Agra. Levantamento da Flora Medicinal de Uso no Tratamento da Diabete e Alguns Resultados Experimentas, VIII Simposip de Plantas Medicinais do Brasil. pp. 23. September 4-6. Manaus-AM, Brazil, (1984).
23. O.A. Costa Estudo Farmacoquimico da Unha-de-Vaca Rev. Flora Medicinal 9 1945 175 189
24. J. Easterling, Traditional Uses of Rainforest Botanicals, (1993).
25. E.T. Miyake Caracterizacao Farmacognostica de Pata-de-Vaca (Bauhinia forficata) Rev. Bras Farmacogn 1 1986 56 68
26. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
27. E.S. Knudsen, and J.Y. Wang Dual mechanism for the inhibitor of E2F binding to Rb by cyclin-dependent kinase mediated Rb phosphorylation Mol. Cell Biol. 17 1997 5771 5783
28. R. Bernards E2F: A nodal point in cell cycle regulation Biochim. Biophys. Acta. 1333 1997 M33 M40
29. W.S. El-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, and J.M. Trent WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
30. J.W. Harper, and S.J. Elledge Cdk inhibitor in development and cancer Curr. Opin. Genet. Dev. 6 1996 56 64
31. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals Cell 78 1994 59 66